GENEMATRIX
Genematrix is developing new diagnostic products for various diseases by developing a globally competitive core platform technologies in the field of molecular diagnostics, which is attracting attention as a high-technology in the line of biotechnology. The Molecular Diagnostic market has high growth rates among in-vitro diagnostics markets and is a high value-added industry that is highly dependent on advanced countries since global companies prevailed the most core technologies. Genematrix, since the beginning of the company, has developed its own technologies that is globally competitive in the field of molecular diagnostics through joint research with domestic and international companies and research institutes.
GENEMATRIX
Industry:
Biotechnology
Founded:
2000-01-01
Status:
Active
Contact:
+82-31-628-2000
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Font Awesome Mobile Non Scaleable Content Nginx Euro PHP PHP 7 COVID-19
Current Employees Featured
Stock Details
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2018-12-20 | Vaccitech | GeneMatrix investment in Series A - Vaccitech | 6 M GBP |